ACTRN12607000566437招募中未知
A randomised dose-response trial to determine the effects of omega-3 fatty acids in treatment of mild hypertriglyceridemia in young women to reduce the risk of cardiovascular disease
niversity of Wollongong0 个研究点目标入组 120 人开始时间: 2007年11月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- Female
入选标准
- •Female, generally healthy, regular menstrual cycles, plasma triglycerides >1.0mmol/L at screening visit.
排除标准
- •Pregnant, irregular menstrual cycles, anemia, or plasma triglycerides < 1mmol/L at screening visit.
研究者
相似试验
招募中
3 期
A randomized clinical trial to determine the efficacy of Affron, a standardised extract of Saffron (Crocus sativus) on mood and cognitive function in healthy adults over 4 weeks.MoodStresscognitive functionSleepAlternative and Complementary Medicine - Herbal remediesMental Health - Studies of normal psychology, cognitive function and behaviourACTRN12614001053617Integrated Health Group Pty. Ltd.150
进行中（未招募）
1 期
A dose finding study of OligoG in patients with CF.MedDRA version: 20.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2018-000378-30-DEAlgiPharma AS168
进行中（未招募）
1 期
A dose finding study of OligoG in patients with CF.MedDRA version: 20.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2018-000378-30-PLAlgiPharma AS180
进行中（未招募）
1 期
A dose finding study of OligoG in patients with CF.MedDRA version: 20.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2018-000378-30-ATAlgiPharma AS168
进行中（未招募）
1 期
A dose finding study of OligoG in patients with CF.MedDRA version: 20.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersCystic FibrosisEUCTR2018-000378-30-GBAlgiPharma AS168